- Home
- »
- Medical Devices
- »
-
Hysteroscope Market Size And Share Report, 2026-2033GVR Report cover
Hysteroscope Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product (Rigid, Flexible, Disposable), By Application (Myomectomy, Polypectomy, Endometrial Ablation, Others), By End Use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts
Market Size, 2025
$270.6MMarket Estimate, 2026
$285.5MMarket Forecast, 2033
$423.8MCAGR, 2026–2033
5.8%Hysteroscope Market Summary
The global hysteroscope market size was valued at USD 270.6 million in 2025 and is projected to grow from USD 285.5 million in 2026 to USD 423.8 million by 2033, at a CAGR of 5.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. Market growth is driven by the rising prevalence of gynecological disorders, increasing adoption of minimally invasive treatments, growing infertility cases, and an expanding geriatric female population.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By product: Disposable segment held the largest market share of around 60.0% in 2025.
- By application: Endometrial ablation led the market with a share of around 25.0% in 2025.
- By end use: Outpatient facilities segment held the largest market share of around 55.0% in 2025.
Regional Highlights
- Largest regional market: North America (40.0% revenue share, 2025)
- By country: The U.S. hysteroscope market led the North American market in 2025.
Market Size & Forecast
- Market size in 2025: USD 270.6 Million
- Estimated market size in 2026: USD 285.5 Million
- Projected market size by 2033: USD 423.8 Million
- CAGR (2026-2033): 5.8%
Prism AI by Grand View Research Free to tryAsk a question about the hysteroscope marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →There is an increase in hysteroscopy procedures due to a rise in the number of patients suffering from gynecological disorders such as uterine fibroids, menstrual issues, ovarian cysts, and ovarian cancer. The procedure is conducted with the help of a hysteroscope, which is a slender, illuminated tube placed into the vaginal canal to inspect the cervix and interior of the uterus. Hysteroscopy procedures may be performed before or following other gynecological procedures such as endometrial ablation or myomectomy.
The increase in the elderly population is projected to boost market expansion as older women are more prone to conditions requiring hysteroscope use, such as abnormal uterine bleeding and fertility evaluations. The anticipated rise in the use of assisted reproductive technology procedures by couples is also predicted to drive market growth. Furthermore, the rising popularity of minimally invasive surgery is also contributing to the higher demand for hysteroscopy procedures. Minimally invasive surgery has become the typical method for treating gynecological diseases. Minimally invasive surgery in gynecological diseases offers decreased pain, shorter hospital stays, less blood loss, and reduced risk of scarring. Therefore, these factors have resulted in the market growth of the hysteroscope market.
Analyst Perspective
The hysteroscope market is growing steadily, driven by rising gynecological disorders, demand for minimally invasive procedures, and greater awareness of reproductive health. Clinicians increasingly use hysteroscopes to diagnose and treat uterine diseases with greater precision, less discomfort, and faster recovery. Expanding healthcare infrastructure, screening programs, office-based procedures, and advances in high-definition imaging, compact instruments, and disposable systems further support growth. Demand for precise, patient-focused solutions creates opportunities for innovative, quality-oriented companies.
Product Insights
The disposable hysteroscope segment dominated the market in 2025, accounting for around 60.0% of the global revenue share, driven by the increasing demand for hysteroscopic procedures and the rising prevalence of gynecological disorders. Disposable hysteroscopes eliminate the need for cleaning and sterilization, reducing the risk of cross-contamination and healthcare-associated infections while improving procedural efficiency. In addition, manufacturers continue to introduce technologically advanced single-use hysteroscopes with enhanced imaging capabilities and ease of use.
The flexible hysteroscope segment is expected to register a steady CAGR during the forecast period. The growth of the segment is attributed to the minimally invasive nature of flexible hysteroscopes, superior maneuverability, and improvements in image quality that facilitate accurate diagnosis and treatment. Increasing investments in healthcare infrastructure and the adoption of advanced hysteroscopy equipment across hospitals and ambulatory surgical centers are further supporting segment growth.
Application Insights
The endometrial ablation segment dominated the market in 2025, accounting for around 25.0% of the global revenue share. The increasing prevalence of abnormal uterine bleeding and other gynecological disorders, along with the growing geriatric female population, continues to drive demand for endometrial ablation procedures. The procedure offers a minimally invasive alternative to conventional surgery while reducing recovery time and improving patient outcomes.
The polypectomy segment is projected to grow at a steady CAGR during the forecast period. Rising incidence of uterine polyps, increasing awareness of minimally invasive gynecological procedures, and growing demand for early diagnosis and treatment are expected to support segment growth. Hysteroscopic polypectomy enables precise removal of endometrial polyps while minimizing patient discomfort and recovery time. For instance, in July 2024, Hologic, Inc. received U.S. FDA 510(k) clearance for the Fluent Pro Fluid Management System, designed to provide uterine distension, monitor fluid deficit, and support diagnostic and operative hysteroscopic procedures, including tissue removal during hysteroscopy.
End Use Insights
The outpatient facilities segment dominated the market in 2025, accounting for around 55.0% of the global revenue share. The segment benefits from increasing preference for office-based hysteroscopy owing to reduced procedure time, lower treatment costs, faster patient recovery, and improved convenience. Growing adoption of minimally invasive gynecological procedures in ambulatory settings continues to support market expansion.
The hospitals segment is expected to register a steady CAGR during the forecast period. Growth is driven by the increasing burden of gynecological disorders, expanding healthcare infrastructure, and continued investments in advanced hysteroscopy systems. Hospitals remain the primary setting for complex diagnostic and operative hysteroscopic procedures owing to the availability of specialized gynecological expertise and advanced surgical equipment.
Regional Insights
North America hysteroscope market dominated the global market with a revenue share of around 40.0% 2025, driven by its advanced healthcare infrastructure, high adoption of minimally invasive gynecological procedures, and the presence of leading medical device manufacturers. Rising awareness of women's health, favorable reimbursement policies, and continuous technological advancements in gynecological endoscopy continue to support market growth. Furthermore, increasing demand for office-based hysteroscopy procedures is contributing to the adoption of advanced hysteroscopy systems.
To learn more about this report,Download Free Sample Report
U.S. Hysteroscope Market Trends
Hysteroscope market in the U.S. held the largest share of the North American market in 2025. Growth is driven by the increasing prevalence of gynecological disorders, expanding access to minimally invasive gynecological procedures, and strong healthcare infrastructure. Government initiatives promoting women's health and continued adoption of advanced diagnostic and operative hysteroscopy technologies are expected to support market growth. In addition, companies in this market are also actively expanding the product across the country. For instance, in May 2024, Minerva Surgical announced the immediate and exclusive distribution of the HERizon disposable hysteroscope in the U.S. The device was introduced to expand office-based hysteroscopy by providing a single-use solution designed to improve workflow efficiency and reduce the need for device reprocessing.
Europe Hysteroscope Market Trends
Europe represented a significant regional market in 2025 due to the increasing prevalence of gynecological disorders, growing awareness of minimally invasive gynecological procedures, and an expanding geriatric female population. Increasing investments in women's healthcare and the adoption of hysteroscopy for diagnosis and treatment of intrauterine disorders continue to support regional market growth.
The UK hysteroscope market is expected to witness steady growth during the forecast period, supported by increasing awareness of women's health, rising demand for minimally invasive gynecological procedures, and the adoption of evidence-based clinical practices. In September 2024, the Royal College of Obstetricians and Gynaecologists (RCOG) released an updated Green-top Guideline on Outpatient Hysteroscopy, strengthening recommendations for pain management, informed consent, clinical competency, and standards of care. The revised guidance is intended to improve the quality of care and optimize the patient experience during outpatient hysteroscopy procedures.
Asia Pacific Hysteroscope Market Trends
Asia Pacific held a significant share of the global market in 2025 owing to improving healthcare infrastructure, increasing awareness of women's reproductive health, and growing demand for minimally invasive gynecological procedures. Rising healthcare expenditure and continued investments in advanced medical technologies are expected to accelerate the adoption of hysteroscopy systems across the region.
Hysteroscope market in China is expected to witness significant growth during the forecast period due to the increasing prevalence of gynecological disorders, improving healthcare infrastructure, and growing adoption of minimally invasive surgical procedures. Continued investments in women's healthcare services and expanding access to advanced gynecological diagnostics are expected to support market expansion.
Key Hysteroscope Company Insights
Some of the major companies in the hysteroscope market are Olympus, Stryker, Karl Storz SE & Co. KG, Boston Scientific Corporation and more. Companies are focusing on improving services with the help of collaboration, launching new products, and market expansion in developing regions.
- Hologic, Inc. is a medical technology company that specializes in products related to women’s health. The company manufactures and sells medical devices that are used for diagnostics, medical imaging, and surgery.
- Medtronic is a medical technology company that specializes in designing, developing and manufacturing of medical devices and solutions. The company operates in divisions such as spinal and biologics, cardiovascular, neuromodulation, diabetes, and more.
Key Hysteroscope Companies
The following key companies have been profiled for this study on the hysteroscop market.
-
B. Braun SE
-
Boston Scientific Corporation
-
Cook
-
CooperSurgical Inc.
-
Hologic, Inc.
-
Karl Storz SE & Co. KG
-
Medtronic
-
Olympus Corporation
-
Richard Wolf GmbH
-
Stryker
Recent Developments
-
In May 2025, Minerva Surgical expanded its hysteroscopy product portfolio with the introduction of the HERizon Hysto-Kit, a sterile, single-use procedural kit supplied in a pre-assembled format for office-based hysteroscopy. Designed to minimize procedural preparation and simplify clinical workflows, the kit supports greater efficiency and consistency during hysteroscopic procedures.
-
In October 2024, Minerva Surgical entered into a strategic partnership with Blackmaple Group (BMG) and WHAAPA to expand access to office-based women's health solutions, including hysteroscopy technologies, across physician practices.
Hysteroscope Market Report Scope
Report Attribute
Details
Market size in 2025
USD 270.6 million
Estimated market size in 2026
USD 285.5 million
Projected market size by 2033
USD 423.8 million
Growth rate
CAGR of 5.8% from 2026 to 2033
Base year for estimation
2025
Historical data
2021 – 2024
Forecast period
2026 – 2033
Quantitative units
Revenue in USD million and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, application, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Olympus; Stryker; Karl Storz SE & Co. KG; Boston Scientific Corporation; Richard Wolf GmbH; Medtronic; B. Braun SE; Hologic, Inc.; CooperSurgical Inc.; Cook
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
Global Hysteroscope Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hysteroscope market report based on product, application, end use, and region:
-
Product Outlook (Revenue, USD Million, 2021 - 2033)
-
Rigid Hysteroscope
-
Flexible Hysteroscope
-
Disposable Hysteroscope
-
-
Application Outlook (Revenue, USD Million, 2021 - 2033)
-
Myomectomy
-
Polypectomy
-
Endometrial Ablation
-
Others
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Hospitals
-
Outpatient Facilities
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
The global hysteroscope market size was valued at USD 270.6 million in 2025 and is estimated at USD 285.5 million for 2026.
The global hysteroscope market is expected to grow at a CAGR of 5.8% over the forecast period.
North America dominated with an approximately 40.0% revenue share in 2025.
Some of the key players are Olympus, Stryker, Karl Storz SE & Co. KG, Boston Scientific Corporation, Richard Wolf GmbH, Medtronic, B. Braun SE, Hologic, Inc., CooperSurgical Inc., Cook and others.
The disposable segment accounted for the largest revenue share of approximately 60.0% in 2025.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.